• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Monday, January 30, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Minorities face longer wait times for vital lung cancer treatment, study finds

Bioengineer by Bioengineer
October 25, 2022
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new study has revealed significant racial disparities in how quickly minorities with the most common form of lung cancer receive potentially lifesaving radiation therapy compared with their white counterparts.

Minorities face longer wait times for vital lung cancer treatment, study finds

Credit: Dan Addison | UVA Communications

A new study has revealed significant racial disparities in how quickly minorities with the most common form of lung cancer receive potentially lifesaving radiation therapy compared with their white counterparts.

UVA Cancer Center researchers reviewed data from more than 222,700 patients with non-small cell lung cancer across the country. They found that the mean time to radiation initiation was 61.7 days. For white patients, it was only 60.9 days; for Black patients, it was 65.9 days; and for Asian patients, it was 71.9 days.

These differences can have real consequences, as speedy treatment initiation contributes to better outcomes. A single-week delay in treatment has been associated with a 3.2% and 1.6% increase in the risk of death for patients with stage I and stage II non-small cell lung cancer, respectively.

The troubling findings prompted the UVA researchers to call for further investigation into the underlying causes of the disparities and to urge efforts to ensure equity in treatment access.

“Our results suggest that non-white lung cancer patients have delayed time to cancer treatment compared with white patients, and this is not limited to a particular type of treatment facility,” said senior researcher Rajesh Balkrishnan, PhD, of UVA Cancer Center and the University of Virginia School of Medicine’s Department of Public Health Sciences. “Collaboration among providers and community stakeholders and organizations is much needed to increase accessibility and patient knowledge of cancer and to overcome existing disparities in timely care for lung cancer patients.”

Cancer Treatment Disparities

The UVA researchers say there may be multiple reasons for the racial disparities. They note that non-white patients are more likely to be uninsured, face greater socioeconomic barriers to care and may be perceived by doctors as being at risk for not following through with their treatment plans. In addition, minorities are more likely to report less satisfaction with their encounters with care providers.

“These findings shed light on the potential presence of and impact of structural racism on patients seeking cancer treatment,” the researchers write in a paper in the scientific journal Health Equity. “Further investigation into the societal determinants that perpetuate disparity in time to radiation therapy, and potential interventions in the clinical setting to improve cultural and racial sensitivity among healthcare professionals, is recommended.”

The longest waits for treatment initiation were at academic health systems, the researchers report. They suggest this may be because patients begin their treatment in community hospitals and other local facilities before they need to be transferred to academic facilities that can offer more complex care.

Racial disparities were found across all types of hospitals, however. White patients consistently had the shortest time to treatment, while Asians had the longest, the researchers report.

Ensuring equity in access to cancer care and improving the quality of that care are major missions of UVA Cancer Center, which this year became one of only 53 cancer centers in the country designated a Comprehensive Cancer Center by the National Cancer Institute. The designation recognizes elite cancer centers with the most outstanding cancer programs in the nation. Comprehensive Cancer Centers must meet rigorous standards for innovative research and leading-edge clinical trials.

UVA Cancer Center is the only Comprehensive Cancer Center in Virginia.

Findings Published

The lung cancer findings have been published in the scientific journal Health Equity. The research team consisted of Akhil Rekulapelli, Raj P. Desai, Aditya Narayan, Linda W. Martin, Richard Hall, James M. Larner and Balkrishnan.

To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog at http://makingofmedicine.virginia.edu.



DOI

10.1089/heq.2022.0104

Share12Tweet8Share2ShareShareShare2

Related Posts

Photo

KAIST presents a fundamental technology to remove metastatic traits from lung cancer cells​

January 30, 2023
Research team

HKUMed uncovers an unexpected T cell exhaustion factor driving cancer immunotherapy resistance

January 30, 2023

Pitt study reframes understanding of graft-versus-host disease

January 30, 2023

World-first guidelines created to help prevent heart complications in children during cancer treatment

January 29, 2023

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    64 shares
    Share 26 Tweet 16
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

KAIST presents a fundamental technology to remove metastatic traits from lung cancer cells​

Mixing between species reduces vulnerability to climate change

NSF’s NCSES releases report on diversity trends in STEM workforce and education

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 43 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In